We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Edward Copelan

Edward Copelan MD

Chair, Department of Hematologic Oncology and Blood Disorders; Director of the Hematopoietic Cell Transplantation program, Levine Cancer Institute of Carolinas HealthCare System; Clinical Professor of Medicine at University of North Carolina Chapel Hil

Edward Copelan is chair of the Department of Hematologic Oncology and Blood Disorders and Director of the Hematopoietic Cell Transplantation program at the Levine Cancer Institute of Carolinas HealthCare System and Clinical Professor of Medicine at University of North Carolina Chapel Hill.  He is associate editor of Biology of Blood & Marrow Transplantation and of Bone Marrow Transplantation.  He previously served as Director of the Division of Bone Marrow Transplantation at Ohio State, director of the Leukemia Program at the Cleveland Clinic and on the executive committee of the CIBMTR.

Recent Contributions to PracticeUpdate:

  1. Ibrutinib for Chronic GVHD After Failure of Prior Therapy